Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
Yannick Galipeau, Vinayakumar Siragam, Geneviève Laroche, et al.
EBioMedicine (2021) Vol. 74, pp. 103700-103700
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 110
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 71
Widespread exposure to SARS-CoV-2 in wildlife communities
Amanda R. Goldberg, Kate E. Langwig, Katherine L. Brown, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Immune imprinting: The persisting influence of the first antigenic encounter with rapidly evolving viruses
Mariam Maltseva, Alexa Keeshan, Curtis Cooper, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models
Martín A. Rossotti, Henk van Faassen, Anh Tran, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 27
Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
Katharina Röltgen, Scott D. Boyd
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 69-97
Open Access | Times Cited: 15
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders
Jessica Denis, Annabelle Garnier, Laurence Cheutin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidence
David J. Bean, Janet Monroe, Yan Mei Liang, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 751
Open Access | Times Cited: 6
Plasmon-Enhanced Digital Fluoroimmunoassay for Subfemtomolar Detection of Protein Biomarkers
Anushree Seth, Yuxiong Liu, Rohit Gupta, et al.
Nano Letters (2023) Vol. 24, Iss. 1, pp. 229-237
Closed Access | Times Cited: 13
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Constanza Méndez, Hernán F. Peñaloza, Bárbara M. Schultz, et al.
EBioMedicine (2023) Vol. 91, pp. 104563-104563
Open Access | Times Cited: 12
Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection
A.H. Ayesha Lavell, Jonne J. Sikkens, Arthur W.D. Edridge, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105105-105105
Open Access | Times Cited: 19
Autoantibodies targeting angiotensin‐converting enzyme 2 are prevalent and not induced by SARS‐CoV‐2 infection
Yannick Galipeau, Nicolas Castonguay, Pauline S. McCluskie, et al.
The FASEB Journal (2025) Vol. 39, Iss. 4
Open Access
Cohort profile:Stop the Spread Ottawa (SSO)—a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
BMJ Open (2022) Vol. 12, Iss. 9, pp. e062187-e062187
Open Access | Times Cited: 16
A Serological Multiplexed Immunoassay (MIA) Detects Antibody Reactivity to SARS-CoV-2 and Other Viral Pathogens in Liberia and Is Configurable as a Multiplexed Inhibition Test (MINT)
Brien K. Haun, Albert To, Caitlin A. Williams, et al.
Immuno (2024) Vol. 4, Iss. 1, pp. 108-124
Open Access | Times Cited: 3
Widespread exposure to SARS-CoV-2 in wildlife communities
Amanda R. Goldberg, Kate E. Langwig, Katherine L. Brown, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel
Kevin W. Ng, Nikhil Faulkner, Antoni G. Wrobel, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101507-101507
Open Access | Times Cited: 18
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
Irène A. Abela, Magdalena Schwarzmüller, Agnė Ulytė, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 2
Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy
Michal Podrazil, Pavla Táborská, Dmitry Stakheev, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort study
Sonia S. Anand, Corey Arnold, Shrikant I. Bangdiwala, et al.
CMAJ Open (2022) Vol. 10, Iss. 3, pp. E599-E609
Open Access | Times Cited: 10
Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19
Flávia Fonseca Bagno, Sarah Aparecida Rodrigues Sérgio, Maria Marta Figueiredo, et al.
Journal of Clinical Virology Plus (2022) Vol. 2, Iss. 3, pp. 100101-100101
Open Access | Times Cited: 10
Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding Domain
Beomki Lee, Jae‐Hoon Ko, Kyoung Hwa Lee, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 10
Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
James Nyagwange, Bernadette Kutima, Kennedy Mwai, et al.
International Journal of Infectious Diseases (2022) Vol. 127, pp. 11-16
Open Access | Times Cited: 10
Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
Di Yin, Zirong Han, Bing Lang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 10
Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand
Yifan Li, Mélanie Merbah, Suzanne E. Wollen-Roberts, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 11, pp. 2214-2225
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top